(Q41503987)

1 October 2017

1 reference

title

Gestational trophoblastic diseases and their treatment (English)

1 reference

1 October 2017

P M Fisher

1

1 reference

1 October 2017

B W Hancock

series ordinal

2

1 reference

1 October 2017

publication date

1 January 1997

1 reference

1 October 2017

published in

Cancer Treatment Reviews

1 reference

1 October 2017

volume

23

1 reference

1 October 2017

issue

1

1 reference

1 October 2017

page(s)

1-16

1 reference

Nuclear transplantation in the mouse: heritable differences between parental genomes after activation of the embryonic genome

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Trophoblastic pseudotumor of the uterus.An exaggerated form of “syncytial endometritis” simulating a malignant tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Clinical characteristics of placental site trophoblastic tumor (PSTT).

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Under-registration of gestational trophoblastic disease in the Swedish Cancer Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Hydatidiform mole in England and Wales 1973-83.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Dietary factors and risk of trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Simultaneous choriocarcinoma in mother and newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Medical induction prior to surgical evacuation of hydatidiform mole: is there a greater risk of persistent trophoblastic disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Hydatidiform mole in the elderly: hysterectomy or evacuation?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

1 reference

7 January 2021

Treatment of metastatic trophoblastic disease: good and poor prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Risk and prognostic factors in trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Single-dose actinomycin D in the treatment of postmolar trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT).

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Respiratory failure due to choriocarcinoma: A study of 103 dyspneic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Management of liver metastasis from gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990017-7

7 January 2021

10.1016/S0305-7372(97)90017-7

Identifiers

DOI

1 reference

1 October 2017

1 reference